Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Indacaterol dose finding in persistent asthma
NCT00403637Phase 3Completed
- Sponsor
- Novartis
- Start
- Nov 2006
- Primary completion
- Feb 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of indacaterol in asthma, sponsored by Novartis. Started Nov 2006; status: completed.
02
Drugs
indacaterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00403637.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00403637.